MCS Data Labs, established in 2013, has early on emphasized…
The REFLOW Berlin pilot, in which MCS is a partner,…
Project starts with kickoff event in Copenhagen Copenhagen (Denmark), June…
ETSI (European Telecommunication Standards Institute) and EENA (European Emergency Number…
MCS was invited as one of twelve eHealth startups to…
As part of the series ‘Companies Introduces Themselves’, MCS Data…
Things we do
EMYNOS is a European Commission-funded project, managed by a European research and innovation consortium in which MCS Data Labs participates. The acronym stands for ‘nExt generation eMergencY commuNicatiOnS’.
Thanks to advances in medical treatment chances to survive cancer have increased over the last decades significantly. Given this situation, research and innovation are needed to monitor and assist post-treatment cancer patients and increase their level of well-being.
The European Commission has approved a research and innovation project titled ‘constRuctive mEtabolic processes For materiaL flOWs in urban and periurban environments across Europe’ (REFLOW)
Supporting MCS’ flagship development SmarKo® this project aims at significantly outperforming existing fall sensors.
Falls in elderly people have become an increasingly alarming issue causing societal and economic harm.
SmarKo Health® System
SmarKo Health® is an award-winning sensor- and application-based technology focusing on the needs of patients and medical experts in the area of remote diagnosis and treatment. The functioning and tested prototype was developed by MCS Data Labs GmbH, Berlin (Germany).